Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Almasan
S-Phase Checkpoints Regulate Apo2 Ligand/Trail and CPT-11-induced Apoptosis of Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Multiple Mechanisms Underlie Resistance of Leukemia Cells to Apo2 Ligand/Trail
Molecular Cancer Therapeutics
Cancer Research
Oncology
221. TRAIL-R2 and HRK Mediate Angiotensin Type 2 Receptor-Induced Apoptosis of Human Prostate Cancer Cells
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Butyrate-Induced Apoptosis in Prostate Cancer Cells
SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis
International Journal of Oncology
Cancer Research
Oncology
TRAIL-induced Apoptosis of Thyroid Cancer Cells: Potential for Therapeutic Intervention
Oncogene
Cancer Research
Genetics
Molecular Biology
The Role of NF- B in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma Cells
Journal of Immunology
Allergy
Immunology
Resistance of Prostate Cancer Cells to Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL/Apo2L) Can Be Overcome by Doxorubicin or Adenoviral Delivery of Full-Length TRAIL
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Ouabain Downregulates McL-1 and Sensitizes Lung Cancer Cells to TRAIL-induced Apoptosis
American Journal of Physiology - Cell Physiology
Physiology
Cell Biology
TRAIL Is a Key Target in S-Phase Slowing-Dependent Apoptosis Induced by Interferon-Β in Cervical Carcinoma Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
